Virax Biolabs Group Limited (VRAX)

NASDAQ: VRAX · Real-Time Price · USD

0.2145

+0.0075 (3.62%)

At close: Mar 6, 2026, 4:00 PM EST

0.2157

+0.0012 (0.56%)

After-hours: Mar 6, 2026, 6:52 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Distribution of Diagnostics Test Kits and PPE Products	6.33K	156.42K	8.56K		123.82K	99.88K
Distribution of Diagnostics Test Kits and PPE Products Growth	-95.95%	1727.11%	-		23.97%	-
Total	6.33K	156.42K	8.56K		123.82K	99.88K
Total Growth	-95.95%	1727.11%	-		23.97%	-

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
United Kingdom	6.33K	156.42K	8.56K		123.82K	99.88K
United Kingdom Growth	-95.95%	1727.11%	-		23.97%	-
Total	6.33K	156.42K	8.56K		123.82K	99.88K
Total Growth	-95.95%	1727.11%	-		23.97%	-

Source: S&P Global Market Intelligence.